Nikhil N. Verma, M.D., an orthopedic surgeon and sports medicine physician with Midwest Orthopaedics at Rush, has been named Professor and Director of Sports Medicine Research for the Department of Orthopedic Surgery at Rush University Medical Center.
Nikhil N. Verma, M.D.: New Director of Sports Medicine Research at Rush
1 min read Premium comments
The October 22, 2015 news release indicates: “Dr. Verma has received recognition for his treatment of shoulder, elbow and knee conditions using advanced and innovative surgical techniques. He performs more than 500 procedures yearly, in addition to serving as a team physician for the Chicago White Sox, Chicago Bulls and Nazareth Academy, LaGrange Park. His highly qualified clinical practice is complemented by his distinguished work in research and academic medicine. Dr. Verma has written a number of book chapters and peer-reviewed manuscripts that have been published in orthopedic and sports medicine journals. He is often an invited speaker or guest surgeon for national and international sports medicine conferences. Additionally, he is the Associate Editor of the Arthroscopy Journal as well as a member of the editorial board for the Journal of Knee Surgery. He has been elected yearly by his peers to “Best Doctors in America” since 2007, and U.S. News & World Report voted him among the top 10-15% of Top Doctors in America.”
Dr. Verma told OTW, “The most interesting aspect of sports medicine research at this time is biologics. In many areas, we have maximized our ability to improve outcomes by building a better mechanical construct. In the future, our ability to directly impact soft tissue to bone healing via biologic augmentation offers the promise of providing patients faster and more complete recovery.”
“My primary goal in this new role is to continue to foster collaborative work within the section of sports medicine and between departments within the university. We are fortunate to have many dedicated clinicians and scientists at Rush who have various areas of expertise. Our success to this point and moving forward is based on a team effort combining the expertise of many talented individuals.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.